Valutazione Della Secrezione Ipofisaria Nei Pazienti Con Adenoma O Cancro Della Prostata

Huggins C. , Russell P. S. : Quantitative effects of hypophysectomy on testis and prostate of dogs. Endocrinology, 39; 1–7 (1946).

Lostroh A. J. , Li C. H. : Stimulation of the sex accessories of hypephysectomized male rats by non-gonadotrophic hormones of pituitary gland. Acta Endocrinol., 25; 1–16 (1957).

Grayhack J. T. , Lebovitz M. : Effect of prolactin on citric acid of lateral lobe of prostate of Sprague-Dowley rats. Invest. Urol., 5; 87–94 (1967).

Farnsworth W. E. : Prolactin and prostate. In: Boynes A. R. , Griffiths K. : Prolactin and carcinogenesis. Alpha Omega Alpha, p. 217–225, Cardiff 1972.

Asano M. : Studies on urinary prolactin with special reference to the carcinoma of prostate. Jap. J. Urol., 93; 901–918 (1967).

Harper M. E. , Peeling W. B. , Cowley T. , Brownsey B. G. , Phillips M. E. A. , Groom G. , Fahmy D. R. , Griffiths K. : Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during estrogen therapy. Acta Endocrinol., 81; 409–426 (1976).

Saroff J. , Kirdani R. Y. , Mingchu T. , Waisman Z. , Murphy G. P. : Measurements of prolactin and androgens in patients with prostatic disease. Surg. Forum, 28; 568–569 (1977).

Hammond G. L. , Kontturi M. , Maattala P. , Puukka M. , Vihko R. : Serum FSH, LH and prolactin in normal males and patients with prostatic disease. Clin. Endocrinol., 7; 129–135 (1977).

Giuiam L. , Pescatore D. , Martorana G. , Giberti C. , Barreca T. , Rolandi E. : Increased serum prolactin pituitary reserve in patients with prostatic neoplasm. Brit. J. Urol., 51; 390 (1979).

Midgley A. R. jr. : Radioimmunoassay: a method for human chorionic and human luteinizing hormone. Endocrinology, 79; 10–12 (1966).

Rolandi E. , Barreca T. , Gallamini A. , Gianrossi R. , Masturzo P. , Murialdo G. , Nizzo Mc. C. : Physiological, pharmacological and pathological hyperprolactinemias. In: Polleri A. , MacLeod R. M. : Neuroendocrinology: biological and clinical aspects. Acad. Press inc., p. 257–286, London 1979.

Yamanaka H. , Kirdani R. Y. , Saroff J. , Murphy G. P. , Sanderg A. A. : Effect of testosterone and prolactin on rat prostatic weight, 5 α-reductase, and arginane. Amer. J. Physiol., 229; 1102–1109 (1975).

Manandhar M. S. P. , Thomas J. A. : Effect of prolactin on the metabolism of androgens by the rat urethral prostate. J. Urol., 119; 517–520 (1978).

Hafiez A. A. , Lloyd C. W. , Bartke A. : The role of prolactin in the regulation of testis function: the effects of prolactin and luteinizing hormone on the plasma levels of testosterone and androstenedione in hypophysectomized rats. J. Endocrinol., 52; 327–332 (1972).

NegroVilar A. , Saad W. A. , McCann S. M. : Evidence for a role of prolactin in prostate and seminal vesicle growth in immature male rats. Endocrinology, 100; 729–737 (1977).

Farnsworth W. E. , Gouder M. J. : Prolactin and prostate cancer. Urology, 10; 33–34 (1977).

Hammond G. L. , Lukkarinen O. , Vihko P. , Kontturi M. , Vihko R. : The hormonal status of patients with benign prostatic hypertrophy: FSH, LH, TSH and prolactin responses to releasing hormones. Clin. Endocrinol., 10; 545–552 (1979).

Farrar D. J. , Pryor J. S. : The effect of bromocriptine in patients with benign prostatic hypertrophy. Brit. J. Urol., 48; 73–75 (1976).

Serment G. , Roulier R. , Martin P. : Utilsation de la bromocriptine (CB 154) dans le traitement de l'adénome prostatique. Presse méd., 6; 1147–1148 (1977).